Skip to main content
. 2016 Nov 22;7(52):86704–86712. doi: 10.18632/oncotarget.13495

Table 2. Allele frequencies in cases and controls, and odds ratio estimates for breast cancer risk.

SNP ID Gene Chromosome position Base change MAF-cases MAF-controls HWE test p-value OR 95% CI p
rs6713088 ACYP2 2p16.2 G/C 0.410 0.428 0.884 0.929 0.695 1.241 0.617
rs12621038 ACYP2 2p16.2 T/C 0.383 0.469 0.666 0.701 0.524 0.936 0.016*
rs1682111 ACYP2 2p16.2 A/T 0.322 0.256 1.000 1.380 1.006 1.892 0.045*
rs843752 ACYP2 2p16.2 G/T 0.303 0.300 0.305 1.016 0.744 1.386 0.922
rs10439478 ACYP2 2p16.2 C/A 0.385 0.441 0.193 0.795 0.595 1.063 0.122
rs17045754 ACYP2 2p16.2 C/G 0.145 0.205 0.508 0.656 0.448 0.960 0.029*
rs843720 ACYP2 2p16.2 G/T 0.295 0.305 0.866 0.953 0.698 1.301 0.763

MAF = minor allele frequency; HWE = Hardy-Weinberg Equilibrium.

OR= odds ratio; 95% CI = 95 % confidence interval.

*

p ≤ 0.05 indicates statistical significance.